Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Hadi, Usman ^a   van den Broek, Peterhans ^b   Kolopaking, Erni P ^a   Zairina, Nun ^a   Gardjito, Widjoseno ^a   Gyssens, Inge C ^c,d  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENERIC DRUG; TETRACYCLINE; ANTIINFECTIVE AGENT; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BLISTER PACK; CROSS-SECTIONAL STUDY; DRUG COST; DRUG INDUSTRY; DRUG LABELING; DRUG MARKETING; DRUG PACKAGING; DRUG QUALITY; INDONESIA; LAW ENFORCEMENT; PHARMACY; PRESCRIPTION; QUALITY CONTROL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; HUMANS; INDONESIA; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUGS;

EID: 77954336857     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-203     Document Type: Article

References (36)

1. Lestari ES, Severin JA, Filius PMG, Kuntaman K, Duerink DO, Hadi U, Wahjono H, Verbrugh HA. Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals. Eur J Clin Microbiol & Infect Dis 2008, 27:45-51. 10.1007/s10096-007-0396-z, 17934766.
2. Hadi U, Duerink DO, Lestari ES, Nagelkerke NJ, Werter S, Keuter M, Suwandojo E, Rahardjo E, Van den Broek PJ, Gyssens IC. Survey of antibiotic use of individuals visiting public healthcare facilities in Indonesia. Int J Infect Dis 2008, doi: 10.1016/j.ijid.2008.01.002.
3. Duerink DO, Lestari ES, Hadi U, Nagelkerke NJ, Severin J, Verbrugh HA, Keuter M, Gyssens IC, van den Broek PJ. Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals. J Antimicrob Chemother 2007, 60:377-384. 10.1093/jac/dkm197, 17595290.
4. Newton PN, Green MD, Fernandez FM, Day NP, White NJ. Counterfeit ant-infective drugs. Lancet Infect Dis 2006, 6:602-613. 10.1016/S1473-3099(06)70581-3, 16931411.
5. World Health Organization (WHO) What encourages counterfeiting of drugs?. World Health Organization (WHO)., http://www.who.int/medicines/services/counterfeit/faqs/15/en/index.html
6. WHO Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs. 1999, 1-60. Geneva: WHO, WHO, WHO.
7. Hall KA, Newton PN, Green MD, Vandenabeele P, Pizzanelli D, Mayxay M, Dondorp A, Fernandez FM. Characterization of counterfeit artesunate antimalarial tablets from Southeast Asia. Am J Trop Med Hyg 2006, 75:804-811.
8. Shakoor O, Taylor RB, Behrens RH. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health 1997, 2:839-845. 10.1046/j.1365-3156.1997.d01-403.x, 9315042.
9. Syhakhang L, Stalsby Lundborg C, Lindgren B, Tomson G. The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharm World Sci 2004, 26:333-338. 10.1007/s11096-004-0558-3, 15683103.
10. Prazuck T, Falconi I, Morineau G, Bricard-Pacaud V, Lecomte A, Ballereau F. Quality control of antibiotics before the implementation of an STD program in Northern Myanmar. Sexually Transmitted Diseases 2002, 29:624-627. 10.1097/00007435-200211000-00002, 12438896.
11. Jack A. Counterfeit medicines. Bitter pills. BMJ 2007, 335(7630):1120-1121. 10.1136/bmj.39412.431655.AD, 18048535.
12. Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother 2007, 60(2):214-236. 10.1093/jac/dkm109, 17550892.
13. Caudron JM, Ford N, Henkens M, Mace C, Kiddle-Monroe R, Pinel J. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health 2008, 13(8):1062-1072. 10.1111/j.1365-3156.2008.02106.x, 18631318.
14. Senior K. Global health-care implications of substandard medicines. Lancet Infect Dis 2008, 8(11):666. 10.1016/S1473-3099(08)70241-X, 18992395.
15. Silverman H, Lydecker M, Lee PR. The drug swindlers. Intern J Health Serv 1990, 20:561-572.
16. Van Crevel R, Nelwan RH, Borst F, Sahiratmadja E, Cox J, van der Meij W, de Graaff M, Alisjahbana B, De Lange WC, Burger D. Bioavailability of rifampicin in Indonesian subjects: a comparison of different local drug manufacturers. Int J Tuberc Lung Dis 2004, 8:500-503.
17. Lee PR, Lurie P, Silverman MM, Lydecker M. Drug promotion and labeling in developing countries: an update. J Clin Epidemiol 1991, 44:49S-55S. 10.1016/0895-4356(91)90113-N, 2045842.
18. McGinnis M, Primo-Carpenter J. Matrix of drug quality reports affecting USAID-assisted countries. Drug Quality Information Program 2008, The United States Pharmacopeial Convention. Rockville, MD.
19. Anonymous Decree of the Head of National Agency of Drug and Food Control Republic of Indonesia on Criteria and Procedure of Drug Registration. No. HK.00.05.3.1950. Jakarta 2003, Anonymous.
20. Anonymous Undang-Undang Obat Keras. Staatsblad no 419 1949, Anonymous.
21. International Business Monitor Indonesia Pharmaceuticals and Healthcare Report Q3 2006. London, UK 2007, 1-65. International Business Monitor.
22. Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a "mystery shopper" study. Pharm World Sci 2002, 24(4):149-153. 10.1023/A:1019506120713, 12227248.
23. British Pharmacopoeia Commission British Pharmacopoeia 2005. 2005, The Stationery Office, British Pharmacopoeia Commission.
24. United States Pharmacopeial Convention The United States Pharmacopeia USP 29. 2006, United States Pharmacopeial Convention.
25. The Minister of Health Decree on the retail prices of generic drugs. No. 156/MENKES/SKIII/2006. Jakarta 2006, The Minister of Health.
26. Ieven M, Van Looveren M, Sudigdoadi S, Rosana Y, Goossens W, Lammens C, Meheus A, Goossens H. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, indonesia. Sexually Transmitted Diseases 2003, 30:25-30. 10.1097/00007435-200301000-00006, 12514438.
27. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AAJ, Johnson A, Hien TT, et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 2004, 9:1241-1246. 10.1111/j.1365-3156.2004.01342.x, 15598255.
28. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A. Counterfeit and substandard antimalarial drugs in Cambodia. Trans Royal Soc Trop Med Hyg 2006, 100:1019-1024.
29. AFO Chinese medicine stores retain their lure in Indonesia. Kabar-indonesia 2006, Jakarta Joyo Press Service, AFO.
30. Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA. Pharmacopeial quality of drugs supplied by Nigerian pharmacies. Lancet 2001, 357:1933-1936. 10.1016/S0140-6736(00)05065-0, 11425415.
31. Hadi U, Duerink DO, Lestari ES, Nagelkerke NJ, Keuter M, Huis in't Veld D, Suwandojo E, Rahardjo E, van den Broek PJ, Gyssens IC. Audit of antibiotic prescribing in two governmental teaching hospitals in Indonesia. Clin Microb Infect 2008, 14:698-707.
32. WHO Specifications for Pharmaceutical preparations. WHO Technical Report Series 948 2008, Geneva: WHO, WHO.
33. World Health Organization Measuring medicine prices, availability, affordability and price components. Report No.: WHO/PSL/PAR/2008.3 World Health Organization.
34. Sagita D, Rachman A. Raids Uncover Counterfeit Drugs. JakartaGlobe J17 March 2009, akarta
35. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health 2002, 8:701-707.
36. World Health Organization WHO Global strategy to contain antimicrobial resistance. 2001, Geneva, Switzerland: WHO, World Health Organization.